Discover 3,590 paid clinical trials in Pasadena, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,590
Safety of MT-401-OTS in Patients With Relapsed AML or MDS
for
Acute Myeloid Leukemia, in Relapse, MDS
Location: Duarte CA, Kansas City KS, Tampa FL
Sponsor: Marker Therapeutics, Inc.
Sex: All
Age: 65+
Code: NCT06552416
Phase 1, Recruiting
SPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer
for
Oropharyngeal Cancer
Location: Duarte CA, Corona CA, Portland OR, Vancouver, Conroe TX,
Sponsor: Canadian Cancer Trials Group
Sex: All
Age: 18+
Code: NCT05451004
Phase 3, Recruiting
Mirikizumab in the Treatment of Chronic Inflammatory Conditions of the Pouch
for
Pouchitis, Pouches, Ileoanal, Pouch, Ileal
Location: Los Angeles CA, Rochester MN, Chapel Hill NC,
Sponsor: University of North Carolina, Chapel Hill
Sex: All
Age: 18 - 70+
Code: NCT06864403
Recruiting
A Study of Subcutaneous Trastuzumab Deruxtecan in Participants With Metastatic Solid Tumors
for
Recurrent or Metastatic Solid Tumors
Location: Newport Beach CA, Las Vegas NV, Nashville TN,
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT07015697
Phase 1, Recruiting
Personalized Health Self-Management Training for Colorectal Cancer Survivors
Get alerts for new trials in your area by subscribing now
Photon Craniospinal Irradiation for the Treatment of Leptomeningeal Disease Secondary to Breast Cancer or Non-small Cell Lung Cancer
for
Anatomic Stage IV Breast Cancer AJCC v8,
Location: Duarte CA, Irvine CA
Sponsor: City of Hope Medical Center
Sex: All
Age: 18+
Code: NCT06910761
Phase 2, Recruiting
A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
for
Ovarian Cancer, Fallopian Tube Cancer,
Location: Duarte CA, Orange CA, Irvine CA, Seattle WA, Chicago IL,
Sponsor: Regeneron Pharmaceuticals
Sex: Female
Age: 18+
Code: NCT04590326
Phase 1, Phase 2, Recruiting
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
for
Carcinoma, Squamous Cell
Location: Duarte CA, Los Angeles CA, La Jolla CA,
Sponsor: Johnson & Johnson Enterprise Innovation Inc.
Sex: All
Age: 60+
Code: NCT04892173
Phase 3, Recruiting
Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer